1 / 38

Immunology for Surgeons : The Basics 101

Immunology for Surgeons : The Basics 101. Principles of Surgery Jeff Warren, MD, FRCSC October 19, 2010. Objectives. The Players -- T-cells and B-cells Immunoglobulins Antigen Recognition Phagocytosis Mediators and Complement Immunization Hypersensitivity Reactions

troy-david
Download Presentation

Immunology for Surgeons : The Basics 101

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Immunology for Surgeons:The Basics 101 Principles of Surgery Jeff Warren, MD, FRCSC October 19, 2010

  2. Objectives • The Players -- T-cells and B-cells • Immunoglobulins • Antigen Recognition • Phagocytosis • Mediators and Complement • Immunization • Hypersensitivity Reactions • Transplant Immunology Basics

  3. Immunology • Conceptually challenging • Complex series of reactions triggered by immunogens • Compartmentalize to simplify, but actual events at molecular and cellular level are “boundary-less” and only partially understood • More we learn the less we know

  4. Introduction • Innate vs Adaptive immunity • Self vs non-self vs altered self • Three phases of immune response: • Cognitive phase • Activation phase • Effector phase • Primary and Secondary responses • Lymphoid organs: primary/secondary • Humoral and Cell-mediated responses

  5. T-cells Thymus CD3+ CD4+ -- Helper and DTH CD8+ -- cytotoxic and suppressor NK Cells Non B-cell, non T-cell lymphocytes +IL-2 --> LAK cells B-cells Bursa fasicularis (birds) Fetal liver and bone marrow CD19+/CD20+ --> plasma cells --> Ab production APCs Lymphocytes

  6. B-cell-->Plasma cell--> Ig production • IgA: secretory, dimer • IgG: most abundant, 2o response, opsonin, C’ binding • IgM: 1o repsonse, C’binding, pentamer • IgE: mast cells and basophils, Type I hypersensitivity • IgD: small quantities, ??

  7. Immunoglobulin

  8. Immunoglobulin -- Fab and Fc

  9. Antigen Recognition • Immunogen: can stimulate immune response • Antigen: recognized by immune system • Immunogenicity: • Complexity: proteins > CHO > nucleic acids > lipids • Size: usually > 5000 Da • Foreigness: xenogeneic > allogeneic > syngeneic > autologous

  10. MHC • HLA in humans on chromosome 6 • With Ag --> Self vs non-self vs altered self • Class I: A and B regions, on all nucleated cells and platelets, recognized CD8+ T-cells --> lysis • Class II: D region, on APCs, recognized CD4+ helper T-cells --> activation and proliferation of helper T-cells (--> cytokines), cytotoxic T-cells (--> lysis), and B-cells (--> plasma cells --> Ab) • Class III: Complement

  11. MHC Class I and Class II

  12. Antigen Presenting Cells (APC) • Capable of activating CD4+ T-cells • Recognition usually occurs in 2o lymphoid organs: spleen, lymph nodes, GALT, Peyer’s patches… • Monocyte and macrophage lineage: • Dendritic cells (skin) • Kupfer cells (liver) • Glial cells (CNS) • B-cell subset

  13. Any nucleated cell APC

  14. Ag Recognition …but not enough… need Co-Stimulatory Signal 2

  15. T-cell receptor

  16. Phagocytosis • Mononuclear (monocytes) vs polymorphonuclear (neutrophils) • Engulfed foreign particle --> phagosome + lysosome --> phagolysosome • Oxygen-dependent mechanisms: • Myeloperoxidase, superoxide anion, H2O2, singlet O2, OH- radicals • Oxygen-independent mechanisms: • Cationic proteins, lysozymes, proteinases

  17. Phases of Phagocytosis

  18. Complement • Component proteins mediators of inflammation and cell lysis • Numbered according to chronological discovery, not necessarily order of activity in cascade reactions • Traditionally divided into Classic, Alternative, and Lectin pathways • Small stimulus --> amplified effect • Initiated by Ag-Ab immune complexes and microbial products • C3a and C5a are chemotactic • Some components are anaphylatoxins --> mast cell degranulation, smooth muscle contraction, increased vascular permeability • End-product is C5b-8 MAC

  19. Complicated!…

  20. …simplified.

  21. Cytokines • Greek -cyto, cell; and -kinos, movement • Large group of cell-signaling molecules: • proteins, glycoproteins, peptides • Grossly include interleukins, lymphokines, and chemokines; redundancy and pleitropism make this classification obsolete today.

  22. Interleukins • IL-1: pro-inflammatory and wound healing; macrophages, neutrophils, fibroblasts, NK cells, endothelial cells, vascular smooth muscle; fever, vasodilation, hypotension, collagen deposition, T-and B-cell proliferation, IL-2 and IL-2R up-regulation • IL-2: “T-cell growth factor” in response to IL-1; NK cells and activated T-cells (auto- and para-crine); up regulates many other cytokines, namely TNF and CSF; deficiency --> SCID • IL-3: hematopoetic growth factor • IL-4: inhibits macrophages • IL-6: inhibits TNF • IL-8: neutrophil chemokine • IL-10: inhibits monocytes/macrophages and anti-inflammatory IL-4, 6, and 10 are “inhibitory” cytokines

  23. IL-2

  24. Tumor necrosis factor (TNF) • Hemmorhagic necrosis in methycholanthrine -induced sarcomas in mice • TNF-alpha: 1o monocytes/macrophages, but NK cells and neutrophils also • Stimulates neutrophils • Endothelial cells --> IL-1 • Procoagulant, increased vascular permeability • Catabolism and cachexia in malignant disease • Apoptotic mediator • Gram negative shock --> endotoxin --> TNF-alpha --> hypotension + DIC • TNF-ß: T- and B-cells • Wound healing, PG and collagen deposition • Cytolytic and cytostatic for many tumor cell lines

  25. Interferons • Glycoproteins • Inhibit viral proliferation via signaling pathways and translation machinery inhibition • INF-alpha -- macrophages • INF-beta -- epithelial cells, fibroblasts, macrophages • INF-gamma -- T-cells and NK cells • Antiproliferative • Can induce differentiation • Stimulate or inhibit a variety of cells to release other cytokines

  26. Chemokines • Low molecular weight cytokines that serve as chemoattractants • 4 cysteine molecules linke by disulfide bonds • C-C or C-X-C and their receptors • IL-8 is actually a chemokine that binds CXCR1 or CXCR2 on neutrophils • 100s of chemokines identified and the catalogue continues to grow!

  27. Immunization • Active: injection of intact attenuated organism or component. Recipient mounts an immune response with the goal being memory • DPT, MMR, pneumovax, HepB, vaccine, polio vaccines • Passive: exogenous active component is given to recipient; immediate but temporary immunity • Antitoxins: C.tetani antitoxin • Immunoglobulin: IgG to immundeficient recipient • Specific immune globulin: RhoGAM (prevent sensitization to Rh Abs crossing placenta from Rh+ infant at delivery)

  28. Who were these guys?… Dr. Albert Sabin Dr. Jonas Salk

  29. Hypersensitivity Reactions • Type I: immediate hypersensitivity • IgE mediated --> mast cells and basophils • Anaphylaxis, hay fever, food allergy • Type II: cytotoxic reactions • IgG and/or IgM mediated; preformed Abs • ABO and Rh incompatibility, myasthenia gravis, Graves disease, ITP • Type III: immune complex mediated • Deposition of Ab-Ag complexes • PSGN, serum sickness, SLE, rheumatoid arthritis • Type IV: DTH • Previously sensitized CD4+ T-helper cells • Tuberculin skin test, contact dermatitis

  30. Transplant Rejection • Hyperacute • Preformed Ab; immediate: “in the OR” • ABO incompatible or high titre donor specific HLA Class I Ab • Acute • T-cell mediated; days to weeks • Treatment and prevention via T-cell depletion: ATG or IL-2R blocker • Chronic (CAN) • Kidneys IF/TA • Immune and non-immune mechanisms • Difficult to predict, prevent, or belay

  31. Alternative: ANTIBODY vs CELLULAR rejection

  32. THE END • Thank you and Good Luck!

More Related